Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-05-29Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma
-
CLINICAL_TRIALS study record update · 2025-05-29A Phase 1/2 Dose-Finding Study Followed by Expansion Cohorts of NGM120, a GFRAL Antagonist Monoclonal Antibody Blocking GDF15 Signaling, in Subjects With Advanced Solid Tumors and Pancreatic Cancer Using Combination Therapy
-
CLINICAL_TRIALS study record update · 2025-05-21A Randomised, Open-Label, Phase 2 Study of Ceralasertib Monotherapy and Ceralasertib Plus Durvalumab in Patients With Unresectable or Advanced Melanoma and Primary or Secondary Resistance to PD-(L)1 Inhibition
-
CLINICAL_TRIALS study record update · 2025-05-16Videoendoscopic Radical Inguinal Lymphadenectomy Versus Open Radical Inguinal Lymphadenectomy in Patients With Penile Cancer: a Feasibility Randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-05-16A Phase II Study to Evaluate the Safety, Tolerability, and Efficacy of IBI363 in Subjects With Advanced Melanoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-05-13A Phase 3 Trial of Fianlimab (Anti-LAG-3) and Cemiplimab Versus Pembrolizumab in the Adjuvant Setting in Patients With Completely Resected High-risk Melanoma
-
CLINICAL_TRIALS study record update · 2025-05-08Prospective Evaluation of Hypoxia in Primary Melanoma
-
CLINICAL_TRIALS study record update · 2025-05-08Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma
-
CLINICAL_TRIALS study record update · 2025-05-08Melanoma Surveillance Photography (MSP) to Improve Early Detection of Melanoma in Ultra-high and High Risk Patients
-
CLINICAL_TRIALS study record update · 2025-05-07Sentinel Lymph Node Localization and Biopsy for Conjunctival and Eyelid Melanoma
-
CLINICAL_TRIALS study record update · 2025-05-06A Phase I Study of the Combination of Chemoradiotherapy With Biologic Therapy for Advanced Head and Neck Cancer
-
CLINICAL_TRIALS study record update · 2025-05-06Neoadjuvant Immunotherapy With Intratumoral Tavokinogene Telseplasmid (Tavo) Plus Electroporation in Combination With Intravenous Nivolumab in Patients With Operable Locally- Regionally Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2025-05-04An Adapted Evidenced-Based Mentored Community Gardening Intervention for Skin Cancer Survivors: A Single-Arm Feasibility Study (Harvest for Health Together Arizona)
-
CLINICAL_TRIALS study record update · 2025-05-02Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
-
CLINICAL_TRIALS study record update · 2025-05-01Survival Monitoring in Russian Cancer Registries
-
CLINICAL_TRIALS study record update · 2025-04-27Investigation of Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
-
CLINICAL_TRIALS study record update · 2025-04-18Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
-
CLINICAL_TRIALS study record update · 2025-04-18Phase I/II Intratumoral Administration of Hu14.18-IL2, With Local Radiation, Nivolumab and Ipilimumab in Subjects With Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2025-04-15LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
-
CLINICAL_TRIALS study record update · 2025-04-13A Phase Ib, Open-label, Multicenter Study of Oral LXH254-centric Combinations in Adult Patients With Advanced or Metastatic KRAS or BRAF Mutant Non-Small Cell Lung Cancer or NRAS Mutant Melanoma
-
CLINICAL_TRIALS study record update · 2025-04-10A Dose-escalation and Expansion Phase I/IIa Study of XP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 Mutation (ENHANCE)
-
CLINICAL_TRIALS study record update · 2025-04-06Immune Profiles Evolution in Patients Treated by Immunotherapy for Melanoma
-
CLINICAL_TRIALS study record update · 2025-04-06A Phase 3, Randomized, Double-blind, Active-Comparator-Controlled Clinical Study of Adjuvant MK-7684A (Vibostolimab With Pembrolizumab) Versus Adjuvant Pembrolizumab in Participants With High-risk Stage II-IV Melanoma (KEYVIBE-010)
-
CLINICAL_TRIALS study record update · 2025-04-04A Phase II, Open-label, Randomized, Multi-center Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal and Acral Melanoma Who Had Not Previously Received Systemic Therapy
-
CLINICAL_TRIALS study record update · 2025-04-04Evaluating the Current Standard of Care for Patients Diagnosed With Malignant Melanoma of the Head and Neck - Access to Staging and Surgical Treatment